[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353154-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353154-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-histone-methyltransferase-nsd3-oncogene-triggers-ribosomal-dna-transcription-interfering-with-fosl2-in-cancer","The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancer","","Ribosome biogenesis is enhanced in cancer, yet the mechanism that activates ribosomal RNA gene expression remains unclear. This study shows that the NSD3 long isoform (NSD3L) remodels chromatin around rDNA and triggers rRNA expression by binding nucleolar proteins and recruiting RNA polymerase I. NSD3L is required for UBTF and Pol I occupancy across the rDNA locus and displaces FOSL2 from a sequence upstream of the rRNA transcription start site. It also competes with SUV4-20H, preventing H4K20me3 deposition, thereby unleashing rDNA synthesis. NSD3L overexpression correlates with nucleolar gene activation across tumor types, supporting NSD3L as an epigenetic regulator and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-histone-methyltransferase-nsd3-oncogene-triggers-ribosomal-dna-transcription-interfering-with-fosl2-in-cancer/353154/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-histone-methyltransferase-nsd3-oncogene-triggers-ribosomal-dna-transcription-interfering-with-fosl2-in-cancer/353154.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does NSD3L play in ribosomal DNA transcription in cancer?","Question",{"text":63,"@type":64},"NSD3L reshapes chromatin around rDNA and triggers rRNA expression by enabling RNA polymerase I recruitment and activity at the rDNA locus.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NSD3L influence FOSL2 binding to rDNA?",{"text":68,"@type":64},"NSD3L binds a narrow upstream rDNA sequence and displaces FOSL2; when NSD3L is removed, FOSL2 binding increases and rDNA expression decreases.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is NSD3L considered a potential therapeutic target?",{"text":72,"@type":64},"NSD3L balances repressors such as FOSL2 and SUV4-20H to unleash rDNA synthesis, and its overexpression is associated with enhanced nucleolar gene expression across multiple tumor types.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353154,1790147719,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nThe histone methyltransferase NSD3 oncogene triggers  \nribosomal DNA transcription, interfering with FOSL2 in cancer  \nFederica Corigliano 1,2,3,6, Marco Gaviraghi 1,6, Alessio Lupi 1,6, Antonino Alex Cartalemi 1,3, Guido Gatti 1, Simona Punzi1,3, Gemma Crupi 1, Oronza A. Botrugno 1, Francesca Bernassola2, Elena Torlai Triglia 1, Aurora Negro1, Francesco Ghini1, Giovanna Musco4, Davide Cittaro 5, Jose M. Garcia-Manteiga 5 ✉, Simona Segalla 1 ✉ and Giovanni Tonon 1,3,5 ✉  \n© The Author(s) 2026  \n\n| | Ribosome biogenesis is pervasively enhanced in cancer, and yet, how the expression of ribosomal RNA genes is triggered remains largely unknown. We found that the long isoform of the histone methyltransferase NSD3, NSD3L, one of the most frequently ampliﬁed genes in cancer, reshapes the chromatin environment surrounding ribosomal DNA (rDNA), thus triggering rRNA expression. An unbiased mass-spec approach revealed that NSD3L binds several nucleolar proteins and localizes to the nucleolus. NSD3L is essential for the binding of Polymerase I as well as of its activator UBTF (Upstream Binding Transcription Factor) to the entire rDNA locus. Conversely, NSD3L binds to a narrow sequence on rDNA located upstream of the rRNA transcription start site (TSS), displacing FOSL2, a member of the FOS/JUN transcription factor family. Upon NSD3L ablation, FOSL2 increases its binding to this region, leading to reduced rDNA expression. These results suggest a surprising, repressive role for FOSL2 on ribosomal gene expression. We also determined that NSD3L competes with another suppressor of rDNA expression, the histone methyltransferase SUV4-20H, thus impeding the deposition of the repressive histone mark H4K20me3 on rDNA. Therefore, NSD3L balances and counteracts the activities of FOSL2 and SUV4-20H on rDNA, unleashing rDNA synthesis. Accordingly, NSD3L overexpression is associated with enhanced expression of nucleolar genes in several tumor types. We hence propose NSD3L as a central epigenetic orchestrator of rRNA transcription in cancer and an enticing therapeutic target for the large group of cancers presenting with NSD3 | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  | |\n|  |  |  |\n| | ampliﬁcations and overexpression. | |\n|  | Cell Death and Disease (2026)17:592; [https://doi.org/10.1038/s41419-026-08768-0](https://doi.org/10.1038/s41419-026-08768-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nRibosome biogenesis is a fundamental and tightly regulated process that controls cell growth and proliferation. Ribosomal RNAs (rRNAs) are key constituents of the two eukaryotic ribosomal subunits 40S and 60S. In a typical diploid human genome, there are approximately 400 ribosomal DNA (rDNA) copies [1, 2] encoding for rRNAs. These rDNA units are arranged in tandem repeats, separated by intergenic spacer sequences (IGS), and are located within the short arm of ﬁve acrocentric chromosomes. The nucleolus, a prominent non-membrane-bound organelle [3], forms around clusters of repeated rDNA genes and serves as the site of rRNA synthesis and early ribosome assembly [4] .  \nA dedicated polymerase, RNA polymerase I (Pol I), drives transcription of rDNA, generating the 47S rRNA precursor rRNA that is processed into 18S, 5.8S, and 28S rRNAs. The localization of Pol I to rDNA is mediated by a series of protein-protein interactions. Pol I recruitment to rDNA is centered on the upstream binding factor (UBTF) [5] . UBTF, Pol I-speciﬁc transcription factor, contributes to the formation of the pre-initiation complex (PIC), recruits the selectivity factor 1 (SL1) to rDNA, and  \nguides transcription initiation and elongation [6] . Conversely, loss of the association of UBTF with rDNA genes promotes the switch from active to silent nucleolar organizing regions (NORs), contributing to rDNA copy inactivation and nucleolar reor","cbCaisR37xCO5GZW","https://ap.wps.com/l/cbCaisR37xCO5GZW","pdf",5812362,15,"English","# Introduction\n## Ribosome biogenesis and rDNA organization\n## RNA polymerase I regulation via UBTF and SL1\n## Chromatin control of rDNA transcription\n## Known repressors and epigenetic modifiers","[{\"question\":\"What role does NSD3L play in ribosomal DNA transcription in cancer?\",\"answer\":\"NSD3L reshapes chromatin around rDNA and triggers rRNA expression by enabling RNA polymerase I recruitment and activity at the rDNA locus.\"},{\"question\":\"How does NSD3L influence FOSL2 binding to rDNA?\",\"answer\":\"NSD3L binds a narrow upstream rDNA sequence and displaces FOSL2; when NSD3L is removed, FOSL2 binding increases and rDNA expression decreases.\"},{\"question\":\"Why is NSD3L considered a potential therapeutic target?\",\"answer\":\"NSD3L balances repressors such as FOSL2 and SUV4-20H to unleash rDNA synthesis, and its overexpression is associated with enhanced nucleolar gene expression across multiple tumor types.\"}]","The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancer | PDF",1790103323,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80611fde4414d0c9c63f825a1ee0bad2.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e78ff0116e45b08aeddc066787d98f5.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/555b426d1b7745b8fb04133acf6e1f3b.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de1acd1ad356b9873862329807744af4.webp",980,1301]